Home›Companies›Healthcare›Verinetics

Verinetics, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 18, 2025·Suggest an edit

About Verinetics

Verinetics is a private company based in Research Triangle Park, North Carolina. It has reported $2,033,017 raised in five offerings on Form D since August 2012. Its chief executive is Jessica Beaver.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 5, 2025Mar 18, 2025$135,000of $1.0M target2$67,500EquityRule 506(b)Form D ↗
Feb 29, 2024Mar 15, 2024$150,000of $750K target2$75,000EquityRule 506(b)Form D ↗
Feb 2, 2022Apr 19, 2023$907,185of $1.0M target9$100KEquity, Conversion of DebtRule 506(b)Form D ↗
May 26, 2015Jun 5, 2015amended Sep 30, 2015$215,000of $600K target2$107KEquityRule 506(b)Form D/A ↗1 earlier filing
Aug 8, 2012Aug 17, 2012amended Apr 28, 2014$625,832fully sold12$52,153EquityRule 506(b)Form D/A ↗1 earlier filing
Total, five offerings$2,033,017

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Verinetics's Form D filed Mar 18, 2025.

TM
Thomas Mercolino
Executive officer and director
JB
Jessica Beaver
President and CEO

Earlier filings also listed Petra Weishaupt-Smith (executive officer, last listed Apr 2023), Ron Vered (director, last listed Sep 2015) and Ed Erickson (director, last listed Apr 2014).

Sources

  1. SECVERINETICS, INC. Form D, filed Jun 5, 2015
  2. SECVERINETICS, INC. Form D, filed Aug 17, 2012
  3. SECVERINETICS, INC. filing history